CSGALNACT1‐congenital disorder of glycosylation: A mild skeletal dysplasia with advanced bone age
Open Access
- 9 November 2019
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 41 (3), 655-667
- https://doi.org/10.1002/humu.23952
Abstract
Congenital disorders of glycosylation (CDGs) comprise a large number of inherited metabolic defects that affect the biosynthesis and attachment of glycans. CDGs manifest as a broad spectrum of disease, most often including neurodevelopmental and skeletal abnormalities and skin laxity. Two patients with biallelic CSGALNACT1 variants and a mild skeletal dysplasia have been described previously. We investigated two unrelated patients presenting with short stature with advanced bone age, facial dysmorphism, and mild language delay, in whom trio‐exome sequencing identified novel biallelic CSGALNACT1 variants: compound heterozygosity for c.1294G>T (p.Asp432Tyr) and the deletion of exon 4 that includes the start codon in one patient, and homozygosity for c.791A>G (p.Asn264Ser) in the other patient. CSGALNACT1 encodes CSGalNAcT‐1, a key enzyme in the biosynthesis of sulfated glycosaminoglycans chondroitin and dermatan sulfate. Biochemical studies demonstrated significantly reduced CSGalNAcT‐1 activity of the novel missense variants, as reported previously for the p.Pro384Arg variant. Altered levels of chondroitin, dermatan, and heparan sulfate moieties were observed in patients’ fibroblasts compared to controls. Our data indicate that biallelic loss‐of‐function mutations in CSGALNACT1 disturb glycosaminoglycan synthesis and cause a mild skeletal dysplasia with advanced bone age, CSGALNACT1‐CDG.Keywords
Funding Information
- NIH Clinical Center (DK096415 (to N. K.), MH106826 (to E. E. D.))
- Japan Society for the Promotion of Science (16K08251 (to S. M.), 19K07054 (to S. M.))
- Takeda Science Foundation
This publication has 44 references indexed in Scilit:
- Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injuryNature Communications, 2013
- Faulty Initiation of Proteoglycan Synthesis Causes Cardiac and Joint DefectsAmerican Journal of Human Genetics, 2011
- Chondrodysplasia and Abnormal Joint Development Associated with Mutations in IMPAD1, Encoding the Golgi-Resident Nucleotide Phosphatase, gPAPPAmerican Journal of Human Genetics, 2011
- Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 Is Necessary for Normal Endochondral Ossification and Aggrecan MetabolismPublished by Elsevier BV ,2011
- Chondroitin sulfate N-acetylgalactosaminyltransferase-1 is required for normal cartilage developmentBiochemical Journal, 2010
- A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis DissecansAmerican Journal of Human Genetics, 2010
- Loss of Dermatan-4-Sulfotransferase 1 Function Results in Adducted Thumb-Clubfoot SyndromeAmerican Journal of Human Genetics, 2009
- Identification of CANT1 Mutations in Desbuquois DysplasiaAmerican Journal of Human Genetics, 2009
- A Recessive Skeletal Dysplasia, SEMD Aggrecan Type, Results from a Missense Mutation Affecting the C-Type Lectin Domain of AggrecanAmerican Journal of Human Genetics, 2008
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007